Pa ge 1 Pa ge 53 American Journal of Medical Science and Innovation (AJMSI) Artificial Intelligence Applications in the Diagnosis and Treatment of Bacterial Infections Sarabjit Kaur1* Volume 4 Issue 2, Year 2025 ISSN: 2836-8509 (Online) DOI: https://doi.org/10.54536/ajmsi.v4i2.5420 https://journals.e-palli.com/home/index.php/ajmsi Article Information ABSTRACT Received: June 28, 2025 Accepted: July 30, 2025 Published: September 13, 2025 In today’s era Artificial Intelligence (AI) is the fruitful and informative tool to treat the bacterial infections. AI features provide the outcomes more effectively, accurately, manifest the disease parameters in shorter period of time which results in safe and potential life. Knowledge Engineering (KE)-based approaches have confirmed in cost-effective, reduce dependency on particular structure and detect the bacterial infection by various mode of testing machines like antimicrobial susceptibility testing (AST) by leveraging machine learning models, Support Vector Machines (SVM), and deep learning architectures such as Convolutional Neural Networks (CNNs) and transformers. Thus, it also enables the bacterial detection through Smartphone-integrated platforms and telemedicine applications. These integrated platforms will help in the research of drugs and vaccines that can use in the antibiotics resistance treatment. Furthermore, AI technology has a widespread deployment in detection of the bacterial resistance strains, transforming the bacterial infection. Its algorithms can easier analyze various data sources like genomic data, clinical data and capture of proper image helps to identify the different bacterial species and strains. AI also assist in the applications of laboratory diagnostics and clinical microbiology to recognize the Gram Positive Or Gram Negative bacteria by plate counting, mass spectrometry for example, MALDI-TOF MS data which accurately classifies different Staphylococcus aureus subspecies. Morphology-based and motion-based microscopic detection, holographic microscopy, colorimetric and fluorescence detection, electrochemical sensors, Raman and Surface-Enhanced Raman Spectroscopy (SERS), and Atomic Force Microscopy (AFM) and AST all these methodologies help in bacterial diagnosis, offering improved precision, reduce the time period between sampling and result resolution. It is very useful novel technique in finding the new antibiotics and to localize the site of action that is directly deliver the drug to the targeted site. AI tool act as a right hand for medical researchers, doctors, nurses that provide best result to overcome the challenges in bacterial infection cure, reduced the side effects; improves patient –compliance and promote healthy life with proper personalization. Keywords Artificial Intelligence, Bacterial Diagnostics, Bacterial Infections, Knowledge Engineering, MALDI- TOF, Personalization 1 Guru Nanak Institute of Pharmacy, Dalewal, India * Corresponding author’s e-mail: sarabkhuttan@gmail.com INTRODUCTION Millions of the people died due to the bacterial infection every year. Researchers had claimed bacterial infections are one of the causes of people death after the heart attack. Accurate and proper investigation of pathogens and suitable drug is vital for the treatment of bacterial infection. Bacterial infections are classify by the shape of bacteria such as bacilli, cocci, spirochetes and vibrio whether they are Gram positive or Gram negative and aerobic or anaerobic. These types help the physician for selection of suitable drugs and vaccines. Long term use of board spectrum antibiotics can lead to resistance. At the same time, surveillance and management of bacterial infections are essential to prevent their spread and safeguard public health. So, AI is the novel technique that offers several applications in order to cure the bacterial infection caused by tuberculosis, STIs (sexually transmitted infections), lungs, skin, urinary tract infection (UTI), GIT and respiratory infections. The fast expansion of AI will result in the positive therapeutic effect in curing the bacterial infections. Artificial Intelligence (AI) is the tool which works like a computer or machine to perform task in a simple way with the help of human intelligence such as object learning, thinking, creativity, innovating the idea, problem-solving and understanding language. AI is the powerful technique that helps in the identification, diagnosis, prevention and treatment of bacterial infections. Furthermore, AI helps the developers and experimenter in the formation of new drugs, vaccines and targeted delivery to the cell, tissue and organs. Machine learning, also helps in studying the drug and excipients profile, structure activity relationship (SAR) in drug development. It helps to predict bioactivity of compounds with the target ligands, proteins or site by using the QSAR modeling and molecular docking. SAR play vital role in knowing efficacy and potency of drug while selectively reducing the toxicity of drug candidates. Machine learning determines the bacterial infection by using automatic and identification of pathogen. It can also analyze by images, data resources obtained from genomic, clinical samples (Blood, urine, stool etc), experiments, laboratory tests and public health database. Apart from this, morphology-based and motion-based microscopic detection, holographic microscopy, colorimetric and Pa ge 54 https://journals.e-palli.com/home/index.php/ajmsi Am. J. Med. Sci. Innov. 4(2) 53-72, 2025 fluorescence detection, electrochemical sensors, Raman and Surface-Enhanced Raman Spectroscopy (SERS), and Atomic Force Microscopy (AFM) and AST all these methodologies help in bacterial diagnosis, offering improved precision, reduce the time period between sampling and result resolution. Table 1: How AI work out to cure the bacterial infection? Invention of New Drug AI algorithms can easily investigate the chemical structures features and their bioactivities to predict the productivity of new drug candidates against resistant bacteria. AI also identifies the potential of new antibiotics at what percentage it can stop or kill the bacterial infection. Detection of Pathogens With the help of AI-powered tools one can easily identify the bacterial pathogens, even those that are resistant to antibiotics. This allows for more targeted and effective treatment options. Streamlined treatment plans Developers with the aid of AI can examine patient data to know individual responses of different antibiotics and customized treatment which provides patients compliance by reducing the risk of side effects and alternative treatment for antibiotic resistance therapy. SAR Analysis 1. Drug activity prediction: AI models help the researchers to rundown the drug and excipients. By studying the different sites of structure one can know the active site that act against bacterial infection. 2. Emphasizing key structural properties : AI helps in identifying the configurationally properties of drug that is biological activity which result to design more effective drugs. 3. Improving drug development efficiency: AI can assist in designing new drugs by predicting the effects of modifications to a drug's structure, which can lead to the development of more potent and selective drugs. Personalization AI can analyze user data to understand the person behaviors, taste that will enables in the tailored experience. Optimizing Drug Delivery AI can be used for optimizing the route and site of delivery of antibiotics infection, thus improving the therapeutic effect and minimizing the side effects. Figure 1: Artificial intelligence facilitates the diagnosis of bacterial infectious diseases Firstly, let us know how bacterial infection occurs. It occurs when the harmful or toxic substances enter in the body and interfering in immune system.Thus, decreasing the body defense system to work against diseases. Skin cuts, uncovered wounds, contaminated food or water, inbreathe of droplets from the infected person, infected blood fluids, direct explore to the contaminated surfaces and then touch it with mouth, eyes or anywhere on the body can lead to bacterial infection. So, with the help of Artificial intelligence these problems can be solved. Pa ge 55 https://journals.e-palli.com/home/index.php/ajmsi Am. J. Med. Sci. Innov. 4(2) 53-72, 2025 Bacteria when cause the infection generally attacks on epithelial cells, although it affects the various types of cells present in the body. Epithelial cells that is responsible for the formation of lining of many organs and tissues, target most as they are present between the internal tissues and external environment. In addition, macrophages and neutrophils (part of immune defense system) are also affected. As we already know bacterial infections spread through various mode of mechanisms- contaminated food and water, by air, direct interact with the infection etc can cause various types of diseases like adhesion, toxins, invasiveness, evading the immune system. So, AI is the most powerful tool to detect which type of infection and which treatment must be best for the patient. Artificial intelligence (AI) has control the disease that is increasing the rapid diagnosis and antibiotic discovery. As conventional criteria of detection takes long time. By AI methods like machine learning, deep learning and computer vision one can finds the type of pathogens or chronic bacterial infection for which someone couldn’t find the treatment to cure. Figure 2: depicts that different mode of AI diagnosis process Figure 3: illustrate the shape of the bacteria diagnosis and how AI tools detect it AI Techniques Used in Bacterial Struture Detection Machine Learning a. K-nearest neighbors (k-NN). b. Support Vector Machines (SVMs). c. Random Forests (RF) and eXtreme Gradient Boosting (XGBoost). d. Gradient Boosting (XGBoost, LightGBM,CatBoost) Deep Learning 1. Convolutional Neural Network (CNNs). 2. Long Short –Term Memory (LSTM) 3. Transformers Other AI Tools 1. Neural network –based sensors 2. Object detection algorithms (R-CNN, YOLO v5) 3. mGPS AI tool. Machine Learning K-nearest Neighbors (k-NN) It helps in classifying the new set of information based on their proximity to calculated data points. Generally, k-NN compares a new data points with the near by neighbors in the information set. It is knoweldgeable in identifiying the different speices of bacteria and classifying the bacterial structure on their properties. Support Vector Machines (SVMs) This learning algorithms classify data of bacteria on their features like genome sequences, shape, size, protein or Pa ge 56 https://journals.e-palli.com/home/index.php/ajmsi Am. J. Med. Sci. Innov. 4(2) 53-72, 2025 lipid structure and metabolic pathways. SVMs identify the antimicrobial resistance in bacteria. It work by categorizing the data points in a hyperplane. Random Forests (RF) and eXtreme Gradient Boosting (XGBoost) It analyze the data by images that is TEM microscopy, gene pool information of bacteria. Apart from this, it can identify and classify the bacterial infection more accurately, efficiency,robustness by combining with the CNNs tool. Furthermore, it is also used in assisting the antibiotics susceptibility and indentifying antimicrobial peptides. It can handle the complex data record. Gradient Boosting (XGBoost, LightGBM, CatBoost) Currently,this AI arithmetic gaining the importance in identying the bacterial structure. It has a power to tackle with the more complex data file. It usually helpful in predicting the cytometric data (measures the physical and chemical characteristics of cells) techniques – flow cytometric, classify the bacteria on their methabolic phases and superbugs (antimicrobial resistance). Deep Learning Convolutional Neural Network (CNNs) It is based on the images information and automatically colonies of bacteria can be find. CNNs used to identify potential new drug of antimicrobial resistance. Apart from this, it also has power in maintaining the quality control processes and ensure the drug purity, safety and efficiency. Long Short –Term Memory (LSTM) It is the advance or improved version of the Recurrent Neural Network (RNN), helps in language translation,recognition of words and forecasting the sequenc of data points that are ordered by time. Time sequence of data is oftenly plotted graphically, time on x- axis and variable’s value on the y-axis. Transformers It is valuable tool in detecting the bacterial infection, mainly vision transformers are used. It detect by analyzing the images of gram –stained smears and chest X-rays. Transformers with the help of clinical data of the patient can determine the bacterial infection. Other AI Tools Neural Network –Based Sensors CNNs artificial intelligence tool is a neural network sensor which is capable of diagnostic the bacterial infection. it is more prominent in speeding up identification processes. Object Detection Algorithms (R-CNN, YOLOv5) This is based upon the image information with the help of deep learning (DL) bacterial images can obtained and examine in detail that is it provide the bacterial structural information as well as diagnosing and identifying the bacterial infection caused by which type of microorganisms and treating infectious diseases caused by pathogenic bacteria. YOLOv5, a powerful object detection method in assisting the bacteria by counting colonies on agar plates. Mostly YOLOv5 is used in identifying the bacterial diseases in rice and bell papers (by bacterial colonies on agar plates). mGPS AI Tool It stands for Microbiome Geographic Population structure. This tool helpful in understanding the climatic conditions in which bacteria is surviving or the origin of bacteria causing an infection. By using mGPS searchers or doctors can predict the bacteria environment in which it grows even from where the bacteria is carried by individuals (like city center, beach etc). It also aid the microbial communities. LITERATURE REVIEW Today, AI is considered a branch of technology and engineering that develop novel concepts and novel solutions to resolve complex challenges. With the passage of time, AI continued progress in electronic speed, capacity, and software programming that might create computers intelligent as human beings. Cheng and Druzdzel (2000) develop an algorithm for evidential reasoning in large Bayesian networks. An adaptive importance sampling algorithm, AISBN that shows promising convergence rates even under extreme conditions is developed. It seems to outperform the existing sampling algorithm consistently. This provides a better substitute to stochastic sampling algorithms that have been observed to perform poorly in evidential reasoning with extremely unlikely evidence. Grunwald (2001) and Halpern (1989) focused on the theoretical foundations of probability updating and predictions under uncertainty. Aim to refine the AI system to give better decisions in the case of uncertainty and work on the safe probability and ignore certain information that leads to have accurate predictions, particularly when handling with the irrelevant data The potential of artificial intelligence (AI) to augment and partially automate research in many scientific disciplines, including the health sciences (Adams et al., 2013; Tsafnat et al., 2014), biology (King et al., 2009), and management (Johnson et al., 2019). In particular, the concept of automated science is raising intriguing questions related to the future of research in disciplines that require “high-level abstract thinking, intricate knowledge of methodologies and epistemology, and persuasive writing capabilities” (Johnson et al., 2019: 292). These debates resonate with scholars in Information Systems (IS), who ponder which role AI and automation can play in theory development (Tremblay et al., 2018) and in combining data-driven and theory-driven research (Maass et al., 2018). With this commentary, we join the discussion which has been resumed recently by Johnson et al. (2019) in the business disciplines. The authors Pa ge 57 https://journals.e-palli.com/home/index.php/ajmsi Am. J. Med. Sci. Innov. 4(2) 53-72, 2025 observe that across this multi-disciplinary discourse, two dominant narratives have emerged. The first narrative adopts a provocative and visionary perspective to present its audience with a choice between accepting or rejecting future research practices in which AI plays a dominant role. The second narrative acknowledges that a gradual adoption of AI-based research tools has already begun and aims at engaging its readers in a constructive debate on how to leverage AI-based tools for the benefit of the research field and its stakeholders. In this paper, our position resonates more with the latter perspective, which is focused on the mid-term instead of the long- term, and well-positioned to advance the discourse with less speculative and more actionable discussions of the specific research processes that are more amenable applications of AI and those processes that rely more on the human ingenuity of researchers. Mintz and Brodie., 2019 AI has begun to incorporated into medicine to improve the pateints compliance by speeding up processes as AI tools like DL helps in achieving the accuracy and opening the way to provide better healthcare. Their search has revelated that with the help of radiological images, pathology slides and patient’s electronic medical records (EMR) evaluated by machine learning helps in the diagnosis process, treatment of patients and to add other treatment to improve outcomes of patients. AI’s transformative potential in business and management has garnered significant research attention (Laurim et al., 2021; Østerlund et al., 2021). As businesses seek to leverage AI for competitive advantage and navigate complexities, literature reviews have become essential in providing insights. AI literature reviews often take a narrow approach, focusing on specific problems within particular research domains. While these literature reviews have contributed valuable insights into their respective fields, they often focus on specific application areas. For example, within information systems, literature reviews have focused on topics such as AI in fitness recommender systems (Venkatachalam & Ray, 2022) and the impact of AI on public governance (Zuiderwijk et al., 2021), while in marketing, reviews have analyzed AI in customer relationship management (Ledro et al., 2022) and consumer-machine relationships (Pentina et al., 2023). Reviews often look at the intersection of these areas, such as Kaufmann et al. (2023), who review the role of tasks in the acceptance of AI and algorithm advice. The traditional approach to diagnosing bacterial infectious diseases, laboratory technicians rely on microbiological and biochemical tests to identify pathogens. It includes bacterial culture, morphological observation, biochemical reaction tests, and serological techniques (Ernst et al., 2006; Váradi et al., 2017). In addition, molecular biology techniques are widely used for the identification of bacterial DNA sequences, of which the polymerase chain reaction (PCR) is a commonly used method (Wilson, 2015; Deusenbery et al., 2021). Although PCR technology is more advanced than traditional biochemical and microbiological methods, it requires a long time to complete the experimental process. Moreover, the integration and application of AI technology not only optimizes the traditional bacterial detection and management process, but also has the potential to bring about a complete revolution (Ho et al., 2019; Wang et al., 2020; Paquin et al., 2022; Howard et al., 2024) Future of AI can be imagined in terms of its capabilities and opportunities, it must be recognized that AI can also present a number of challenges and ongoing issues due to the complexity of the integration of healthcare environments with a purely machine learning-supported AI intervention. Some of the main risks and challenges that have emerged are patient injury from system errors (Aljaaf et al., 2015; Srivastava & Rossi, 2019; Madanan et al., 2021; Dwivedi et al., 2021), patient privacy concerns limiting data access, and the ethical, legal and medical challenges of making decisions about human lives and medical conditions using AI (Liu et al., 2020; Shaban- Nejad et al., 2021). Goodswen et al. (2021) explored the use of AI in medical microbiology and related field. Apart from this, its work is mentioned inrelation to AI in diagnosing and treating the bactrial infections.With the aid of machine learning (ML) microbial interactions can be understand accurately and used in metagenomics to predict microbial functions and analyze data. Moving further, they proved that AI is also playing cruical role in accerelating the vaccine development by understanding the pathogen infection cycles and identifying the active antigens which cure the infection. In supervised learning, algorithms train pre-cataloged data thus enabling for the predictions for new unseen data by drawing the pattern with known outcomes and encompassing classification and identifying the genetic markers associated with traits like virulence and antimicrobial resistance. The use of AI that is with X-rays and CT scans physicians can diagnose and treat the bacterial infections esaily as compared to the traditional methods. AI used to enhance the speed and accuracy of pathogen detection and resistance prediction (Jiang et al., 2022). AI tools were used to track the evolution and transmission patterns of infectious diseases thus, enabling public better health outcomes. Bellini et al. (2022) work in the realm of medical microbiology, supervised machine learning models on labeled datasets predict specific outcomes such as classifying microbial infections and predicting drug sensitivity. This approach results in diagnosis and treatment selection based on known patterns.on the other hand, unsupervised machine learning, analyze unlabeled data, identifying inherent structures and grouping similar data points. Unsupervised machine learning finds applications in group analysis, identification of microbial subtypes and early recognition of infectious threats. Often in the hybrid both methods are employed, leveraging the strengths for diagnosing the infection accurately and insight into microbial interactions.Unsupervised learning, employing clustering methods such as k-means and hierarchical clustering for characterizing complex ecological dynamics. Pa ge 58 https://journals.e-palli.com/home/index.php/ajmsi Am. J. Med. Sci. Innov. 4(2) 53-72, 2025 Regardless of the AI challenges, one of the most important benefits of AI is its support in preventative care in the healthcare system that promotes all humans to become and remain healthy. For example, apps have been used to give patients more control over their health (Antoniou et al., 2018; Jaiman & Urovi, 2020; Samuel et al., 2022), allowing them to make evidence-based decisions on the matters of preventative health issues, such as type 2 diabetes and high blood pressure. However, early detection and diagnostics of health information require many AI apps (Stamford et al., 2016; Siddiqui et al., 2018; Kumar & Suresh, 2019). These AI apps are used in a variety of settings to diagnose different types of illnesses for precise, rapid and reliable results (Ribbens et al., 2019; Sasubilli et al., 2020; Jahan & Tripathi, 2021). At the simplest level, AI performs a significant level of comparative analysis using Big Data so that information from a patient is compared with data and digital images from huge datasets compiled from other patients in relevant and related settings (Charan et al., 2018; Somasundaram et al., 2020). This type of self-learning mechanism recognizes patterns and provides information for medical practitioners to support their diagnosis and intervention strategies (Charan et al., 2018; Woo et al., 2021). While supporting these complex medical procedures, AI technologies can also improve the efficiency of medical care administration (Deng et al., 2019; Daltayanni et al., 2012). AI-powered diagnostic tools can enhance bacterial detection by using low-cost smart gadgets based images process, cloud-based diagnostic platforms and computerized electronic clarifications which helps to diagnosis the clear images of bacterial infection microorganisms and their shape. It gives better results and counter plot the disease ratio Min et al., 2021; Yu et al., 2023. Lee et al. (2024) Artificial intelligence (AI) integration help in the bacterial infection diagnostics and AST offers an effective solution to many challenges. Lee research has shown that AI has remarkable potential in automating data analysis, improving diagnostic precision (Lee), and accelerating time to results. AI algorithms, such as machine learning (ML) and deep learning (DL) models, can easily analyze and modify the complex datasets with high throughput, enabling faster, more accurate bacterial identification and susceptibility profiling. MATERIALS AND METHODOLOY Bacterial infection can be diagnosised by following methods:- 1 Clinical evaluation 2. Microscopy 3. Culture techniques 4. Biochemical tests 5. Serological assays 6. Molecular methods These techniques assist in detecting the existence of bacteria, identifying the particular type of bacteria, and evaluating its sensitivity to antibiotics. Clinical Evaluation and Sample Collection Healthcare professionals evaluate symptoms, conduct physical examinations, and may request imaging studies (X-rays, ultrasound, MRI, CT scans) to identify signs of infection, especially in internal organs. Samples such as blood, urine, sputum, or swabs from infected regions are gathered for additional analysis. For example, in direct testing of antigens in clinical samples has significantly contributed to the swift identification of species. Urine antigen testing has been extensively utilized for detecting pathogens in respiratory infections caused by Legionella pneumophila and Streptococcus pneumoniae. Antigens released by these pathogens and excreted through the urinary tract are typically identified using enzyme immunoassay (EIA) or lateral flow assay (LFA). Although antigen testing offers a reduced turnaround time (TAT), it is hindered by low sensitivity and specificity, particularly in children colonized with S. pneumoniae, and it cannot provide profiles of antibiotic susceptibility or other epidemiological information. The rapid detection of antigens from various clinical samples, such as blood, throat swabs, synovial fluid, pleural fluid, and cerebrospinal fluid (CSF), has been previously investigated but is not widely implemented in clinical practice. A significant retrospective multicenter study evaluated the clinical effectiveness of rapid bacterial antigen detection through latex agglutination and found them to be expensive with no observable clinical advantage. Nucleic acid amplification testing (NAAT) or polymerase chain reaction (PCR) tests represent a dependable non-culture method for microbial detection, commonly employed in laboratories worldwide for diagnosing a diverse range of microbial pathogens. Moreover, multiplex PCR integrates multiple primers and probes within a single reaction tube to amplify gene targets from various pathogens. This highly sensitive technique enhances diagnostic yield and can be applied to numerous clinical specimens, including respiratory secretions, CSF, sterile fluids, and diarrheal feces. However, the limitations of PCR testing include the reporting of incidental findings, an inability to differentiate between colonization and infection, the necessity for skilled operators and a specialized laboratory setting, and the lack of antibiotic susceptibility data. Additionally, PCR will only identify pathogens that are specifically targeted by the assay design, potentially missing rare and unexpected organisms or strains with variations. Microscopy The direct examination of samples under a microscope, possibly utilizing staining methods like Gram stain, can disclose the presence and morphology of bacteria. This technique aids in the preliminary identification based on characteristics such as shape, size, and staining properties. Bright-Field Microscopy This is the most prevalent form of microscopy utilized, frequently alongside with Gram staining. Pa ge 59 https://journals.e-palli.com/home/index.php/ajmsi Am. J. Med. Sci. Innov. 4(2) 53-72, 2025 Gram Staining This technique categorizes bacteria into Gram-positive and Gram-negative groups based on their cell wall composition, offering insights into the bacterial identity. Other Staining Techniques Depending on the suspected infection, alternative stains such as acid-fast stains (for mycobacteria) or capsule stains (for detecting capsules) may be utilized. Wet Mount Microscopy This technique involves the examination of a sample within a liquid medium, commonly used for detecting bacteria in bodily fluids like cerebrospinal fluid or for identifying bacteria in vaginal or wound swabs. Fluorescence Microscopy This method employs fluorescent dyes that attach to specific bacterial components, facilitating highly specific and sensitive detection of bacteria. Culture Techniques Samples are cultivated on various media to promote bacterial growth. Selective media are employed to isolate particular types of bacteria. The growth characteristics, colony morphology, and biochemical reactions of the isolated bacteria are subsequently examined. Biochemical Tests These assessments evaluate the metabolic characteristics of bacteria, including their capacity to utilize specific sugars or produce certain enzymes. An example is the coagulase test for Staphylococcus aureus. A coagulase test is a biochemical assay utilized to distinguish Staphylococcus aureus from other species of Staphylococci, such as S. epidermidis and S. saprophyticus, based on their capacity to produce the coagulase enzyme. Coagulase can be identified using two distinct methods: the tube test and the slide test. Slide Test 1. Approximately 10 µl of deionized water or physiological saline is placed on a slide. 2. Several colonies from a fresh culture are gathered with an inoculating loop and emulsified into the water to create a smooth, milk-colored suspension. 3. A drop of rabbit or human plasma is then added to the slide, and clumping is observed immediately, ensuring it does not exceed 10 seconds. Tube Test 1. The plasma is diluted with physiological saline (0.2 ml of plasma is added to 1.8 ml of saline). 2. 5 ml of the diluted plasma is subsequently transferred to a test tube, followed by the addition of approximately 5 drops of the test organism culture. 3. The contents of the test tube are mixed and incubated at 37°C for one hour. 4. Finally, the tube is examined for clot formation. If no clotting is detected, the tube should be checked at 30-minute intervals for up to 6 hours. Figure 4: represents the result of different coagulase test appearance Serological Identification Serological assessments identify bacterial antigens or antibodies in patient samples. Elevated or increasing titers of specific IgG antibodies or the detection of IgM antibodies may indicate or confirm a diagnosis. Working of Serological Tests A blood sample is collected, and the serum, which is the liquid component of the blood, is isolated. The serum is subsequently analyzed for the presence and quantity of specific antibodies through various methods such as: ELISA (Enzyme-Linked Immunosorbent Assay) A widely used technique that employs antibodies to identify antigens or the reverse. Pa ge 60 https://journals.e-palli.com/home/index.php/ajmsi Am. J. Med. Sci. Innov. 4(2) 53-72, 2025 Agglutination Tests Identify antibodies that induce the clumping of cells or particles. Complement fixation tests Identify antibodies by assessing the consumption of complement proteins. Immunofluorescence Assays Utilize fluorescently labeled antibodies to identify antigens or other antibodies. The outcomes of these tests can reveal whether an individual has been exposed to a specific pathogen or if their immune system is reacting to a vaccine. Molecular Methods Molecular techniques such as PCR (Polymerase Chain Reaction) amplify specific bacterial DNA or RNA sequences for identification. These methods are highly sensitive and specific, capable of detecting even non- culturable bacteria. MALDI-TOF MS (Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry) is another molecular technique utilized for rapid bacterial identification through the analysis of protein profiles. Antimicrobial Susceptibility Testing (AST) AST evaluates the efficacy of various antibiotics against the identified bacteria. This information assists in determining the appropriate antibiotic treatment. Other Techniques Immunofluorescence and immuno-peroxidase staining can identify specific microorganisms. Both techniques employ antibodies to attach to specific antigens; however, they vary in their visualization of the antibody-antigen complex. Immunofluorescence (IF) utilizes fluorescent dyes (fluorophores) linked to antibodies, whereas immunoprecipitation (IP) employs enzymes (such as horseradish peroxidase) that facilitate a reaction resulting in a colored precipitate. Techniques Immunofluorescence Mechanism A fluorescent dye (fluorophore) is either directly or indirectly linked to the antibody that attaches to the target antigen. Visualization The tissue is analyzed using a fluorescence microscope, where the fluorophore emits light at a designated wavelength when stimulated by a light source. Advantages 1. High sensitivity. 2. Allows for the detection of multiple targets at once (multicolor IF). 3. Can be conducted on either frozen or fixed tissue. Disadvantages 1. Requires a specialized fluorescence microscope. 2. Fluorescence may diminish, complicating the long- term storage of slides. 3. May exhibit lower specificity compared to IP in certain instances Immuno-Peroxidase (IP) Mechanism An enzyme, typically horseradish peroxidase, is linked to either the antibody or a secondary antibody. This enzyme facilitates a reaction with a substrate, resulting in a colored precipitate at the location of antigen-antibody interaction. Visualization The tissue is analyzed using a standard light microscope. Advantages 1. It is more durable and less susceptible to fading compared to Immunofluorescence (IF). 2. It enables permanent staining and the ability to archive slides. 3. It can be applied to fixed and paraffin-embedded tissues. In certain instances, it may exhibit greater specificity. Disadvantages 1. It may demonstrate lower sensitivity than Immunofluorescence. 2. The process can be more time-intensive. 3. There is a risk of background staining due to the activity of endogenous peroxidase. AI methods can be broadly classified into three main types namely :- 1. Symbolic AI 2. Machine learning 3. Evolutionary computation Symbolic AI It is also called as classical artificial intelligence or logic- based artificial intelligence. It is define as the a subfield of AI that focuses on logic–programming that is on the symbols and logical reasoning to solve problems rather than numerical data. It involves the certain rules and knowledge to perform the tasks like logical reasoning, problem-solving and language understanding. It developed applications such as knowledge-based system,symbolic mathematics, theorem proofs, automated planning and scheduling system. Researchers in the 1960s snd the 1970s eventually stated that Symbolic AI with machine learning successly predict the logic theorist and Samuel’s checkers playing program. This approach is highly interpretable, as it can easily trace the reasoning process to the logical rules applied. It allows the system’s rule to Pa ge 61 https://journals.e-palli.com/home/index.php/ajmsi Am. J. Med. Sci. Innov. 4(2) 53-72, 2025 modify or manipulate the ideas or a new information. It is very useful techique as compared to machine learning – it doesnot require the vast numerical data, it is based on knowledge, representation and reasoning. Symbolic AI depends on the problem domain and data availability whereas machine learning requires large data records to learn and draw the pattern and make predictions. Apart from this, it can help in the hybrid systems that is combining symbolic AI with other AI tools like neural networks to increase their strength. Key points of Symbolic AI Knowledge Representation:- Symbolic AI has ability to represent the knowledge as reasonable statement, rules and symbolic representations. Symbolic Reasoning In this context, symbols and rules are manipulated to draw inferences and derive results. Logical Inference With the aid of symbolic AI, researchers can perform the tasks related to logic–based reasoning such as,problems solving and predicting upcoming challenges. Rules- Based Systems In rule-based systems, human made rules to sort, store, modify and manipulate the data. It describes how the system will work in the particular situations by following the different sets of rules. values or converting data formats. Feature Engineering Identifying and selecting relevant features from the data that can be used as input for the model is crucial. This process can involve creating new features or transforming existing ones to improve the model’s performance. Model Selection and Training Choosing the appropriate machine learning algorithm (e.g., supervised, unsupervised, or reinforcement learning) and training it on the prepared data is a key step. This involves adjusting the model’s parameters and evaluating its performance. Model Evaluation and Validation After training, the model’s performance needs to be evaluated using metrics and techniques like cross- validation to assess its accuracy and generalization ability. Deployment and Monitoring Once the model is validated, it can be deployed to make predictions or decisions in real-world scenarios. Continuous monitoring of the model’s performance and retraining it with new data is often necessary. Types of Machine Learning Algorithms There are four types of ML Supervised Learning This type of ML uses labeled data to design models that can make predictions or classifications. It can handle the regression problems where input and output variables have a linear relationship. For example in weather prediction, market trend analysis etc. Unsupervised Learning It analyzes unlabeled dataset and discover patterns and structures without any supervision, such as clustering or dimensionality reduction. It is also help to identify typical relations between the large dataset variables. It can be used in the market data analysis. Reinforcement Learning It is feedback based process. It automatically takes the information from hit and trial method and solves the problems. It takes action, learns from the experiences and improves performance. It aims to maximize the rewards by doing good tasks and improved productivity. Semi-supervised Learning It is the combination of both supervised and unsupervised machine learning. It helpful in labeled and unlabeled data for training but more useful when labeled data is limited. Evolutionary Computation It is the collectively the efforts of nature-inspired AI algorithms as well as computer science that optimizes the Machine Learning (ML) It is a subfield of AI that focus on data or past experiences enabling the computer to slove the problems without the human interruption. It depends on algorithms to inform what actions are taken and what outcomes come or decisions. Data Collection and Preparation Machine learning algorithms require data to learn from. This involves gathering, cleaning, and organizing data, often including preprocessing steps like handling missing Pa ge 62 https://journals.e-palli.com/home/index.php/ajmsi Am. J. Med. Sci. Innov. 4(2) 53-72, 2025 biological evolution. It can provide the best solutions for a variety of prooblems like genetic mutation, hereditary problem. Evolutionary Processes that mimic biological evolution includes inheritance,mutation and natural selection. Working of EC: 1. Initialization: The primary step is randomly population of potential solutions is created. 2. Evaluation: According to the fitness parameter each solution is evaluated that measures its performance. 3. Selection: The best solutions are selected to reproduce and contribute to the next generation. 4. Recombination: Selected solutions are combined to create new offspring. 5. Mutation: Random changes are introduced to the new offspring. 6. Iteration: The process is repeated, with each generation refining the solutions until a satisfactory solution is found. Benefits of EC 1. By using EC, one can handle the complex problems and variables to solve the relationships that are difficult for traditional algorithms to solve. 2. Robustness: EC algorithms are often robust to noise and variations in the problem space. 3. EC can be used in various fields, including engineering, finance, and bioinformatics. Examples of EC Applications 1. It finds the best solution to a problem, such as minimizing costs or maximizing performance. 2. With the help of machine learning, designing and optimizing machine learning models can be made. 3. It helps in developing algorithms for robot navigation and control. 4. It can design new molecules for drug development Others Distributed Ledger Technology (DLT) DLT integrated with AI describes a novel and advanced method to achieve the intelligent, resilient, and safe handling of electronic health record data. DLT is an innovative and rapidly growing method for recording and sharing data across different data stores (ledgers). It is secure, immutable, and readily available. It can allow patients to take control of their own data, eventually generating trust in an industry that matters to all of us. Metaverse It a virtual universe that is mirror the physical world with the social, economies and ecosystems interactions. It is giving a new shape of digital existence, where the boundaries between the real and virtual worlds blur. AI role in the metaverse is complex. AI algorithms simulate the respond between user and creation (environment) which in return provide opportunities for personalized treatment. Additionally, AI is acting as the catalyst for driving new techniques enhancing user experience. Surgeons can use the metaverse and AI to do surgeries which are complicated or can practice the surgery before doing on the patients. Application of AI In the Diagnosis of Bacterial Infection Identification of Pathogen with AI AI can algorithms can analyze various data sets by performing mass spectrometry, microscopy images and images capture by normal mobile, easily to identify the bacteria type. AI Enhances Accuracy With the help of AI powered tools we can achieve the accurate result in indentifying the different bacterial genes, including their subtypes and antibiotic resistant strains. For examples: - AI can predict more complex techniques like Raman and SERS very clearly. Two Staphylococcus aureus subspecies can identify very uniquely with the AI algorithms- MALDI-TOF MS correctly. Furthermore, AI used to study autoinducer-2 (AI-2) in S. aureus, giving the path to know the attachment of molecules involved in between the species board casting and influencing anaerobic-bacteria formation. Aureus NCTC8235 and AI-2 together can regulate the gene expression. AI Role In Pandemic And Epidemic Surveillance of Bacterial Infectious Diseases Artificial intelligence (AI), or machine learning, is an ancient concept based on data analytics. AI techniques are useful in the computational methods to survey the record file, single out patterns, pick out the high risk population and grasping disease mechanisms. During the COVID-19 pandemic, AI tools were used in genome sequencing, development of drug and vaccine, identifying disease and his causative organism, monitoring disease spread, and tracking viral variants. AI-driven approaches complement human-curated ones, including traditional public health surveillance. The hybrid models of AI that is ML (machine learning and DL (Deep Learning) are used in the detection of disease cause. Apart from it, Infectious disease dynamics (IDD) and dynamic Bayesian networks (DBN) models helps in finding the spread of disease and its accuracy helps in knowing the strength of the spread of disease. All these specialized tools help in the epidemiology superintendence of the disease, data analysis and interpretation. For example, machine learning models can predict in advance the risk of Clostridioides difficile infection among patients in large hospitals, allowing healthcare teams to implement preventive measures proactively before infection occurs (Oh et al., 2018; Tilton & Johnson, 2019). Clinical Applications of AI In Identification And Management of Bacterial Infection AI tools in clinical testing have abundant uses in diagnosis, management of disease and optimizing the health hazards of the patients. It can analyze by X-rays, MRIs and CT Pa ge 63 https://journals.e-palli.com/home/index.php/ajmsi Am. J. Med. Sci. Innov. 4(2) 53-72, 2025 scans. AI in radiology, images help in analyzing the disease which reduces the interpretation time. Furthermore, in cardiology AI features help in diagnosing the cardiac activities that is with the help of ECG report it’s very simple to predict the heart attracts chances. Figure 6: Following are the key applications of AI in the clinical practice For example in case of pneumonia, the alveoli, small sacs within the lungs, are filled with pus and fluid, which makes breathing painful and limits oxygen exchange. There are more than 30 different causes of pneumonia, and they are grouped accordingly: bacterial pneumonia, viral pneumonia, mycoplasma pneumonia and other pneumonias. AI tool artificial neural networks (ANNs) based on deep learning shown a promising response in diagnosing the pneumonia causative organism accurately and treatment for particular bacterial infection caused by which type of pneumonia. AI Act As Paradigm Shift In Drug Discovery And Development For treating the bacterial infection one of the difficult challenges are resistant to antimicrobial agents and diverse of bacteria. In 2019, globally, it has reported that above 4 million people died due to resistance of antimicrobial. Bacteria have acquired the resistance to the antimicrobial drugs as microbes adapted to the environment, genetic mutation which reduces the efficiency of antimicrobial drugs. Additionally, diversity of bacteria and interaction of bacteria and host creates complexity which results in the management or difficult for treatment. So, AI technologies simulates the complex interactions between pathogens, host and drug, thus helps in revealing the features of infections and optimizing the drug and vaccine designs. AI tools are the boons to the searchers that have huge benefits in the drug and research development. It provides new strategies to overcome the problems of drug resistance. Models of AI can help the developers in predicting the drug physicochemical properties identify promising drug candidates and provide best match to formulate and design the drug. For example, De Novo. Drug Design AI can generate novel molecular structures with specific biological properties, enabling the design of drugs from scratch. Moving further, AI can identify the relationship between pathogen, target site, genotype and chemotype, providing the best come out way to breakout the antimicrobial resistance and provide therapeutic effective drugs. AI easily analyzes the molecular character and predicts the binding affinities of the target ligands and which compound can work more potentially. For e.g.- tuberculosis (TB) and multi resistant infections, AI by the chest X-ray, coughs sounds and genomic analysis, drugs that develop the resistant with all these data information we can find the effective treatment for T.B patients. Current studies that revealed that AI tool especially machine learning (ML) helps in diagnosis, prediction, understanding the causes, treatment and management of disease. It can identify the failure of antibiotics and its reason behind it. From that information, searchers can analyze and generate a new molecule of drug and vaccine to cure T.B and multi-resistant infection. Lastly, the application of AI in predicting DR can aid in the personalized selection of medications, avoiding unnecessary antibiotic use, and reducing the spread of DR strains. Improving patient treatment outcomes and quality of life but also contribute to guiding future research and clinical practice, driving advancements in the field of healthcare. AI Can Predict And Analysis The Toxic And Side Effects of The Drugs In the recent studies it has revealed that AI algorithms easily and quickly predict the toxic effect of drugs by determining the large data record (from clinical trial data, Pa ge 64 https://journals.e-palli.com/home/index.php/ajmsi Am. J. Med. Sci. Innov. 4(2) 53-72, 2025 patient reports etc), identify the patterns and predict outcomes. By analyzing the pharmacokinetics data, safe dose amount can be calculated (dose regimen) and minimizing the side effects. For example the increase of antibiotic resistance, tigecycline a new broad-spectrum of class synthetic tetracycline antibiotics (glycylcycline antibiotic) is widely used in the tissue infections, abdominal infections caused by pneumonia. It works by inhibiting bacterial protein synthesis, act as bactericidal. Apart from this, it can be evaluated by the ratio of AUC0- 24 to the minimum inhibitory concentration (MIC) of pathogens. However, tigecycline may cause nausea, vomiting, diarrhea and a few patients have elevated serum aminotransferase, especially in critically ill patients. AI tools with the combination of physiologically based pharmacokinetic (PBPK) predict the ADME parameters. AI Helps In Come The to An End Bleeding In The Upper Gastrointestinal Track Caused by Helicobacter Pylori Bacterial Infection Helicobacter pylori are the bacteria which attacks the lining that protects the stomach. The bacteria make an enzyme called urease which neutralizes the acids in the stomach. H. pylori also weaken stomach’s lining. Then the stomachs cells are at high risk of explore or hurt by acid and pepsin, strong digestive fluids. That can lead to sores or ulcers in stomach or duodenum. Gastrointestinal endoscopy information can assist AI tools particularly; machine learning can overcome the problem of upper GIT bleeding by bolstering risk assessment, helps in decision making of dose regimen and positively improving the results.AI tools and CAD has shown a potentially result outcomes to analyze increasing loads of numerical and categorical data in short times. It is also notably with AI algorithms achieving regulatory approval for AI-assisted colorectal polyp detection (computer-aided detection [CADe]) and characterization (computer-aided diagnosis [CADx]) in colonoscopy. AI Speeding Up Vaccine Development AI-enabled computational models help to simulate various molecular configurations of the spike protein which help the developers to assess the configuration and provoke an effective immune response. AI criteria in vaccine development as follows:- Antigen Selection AI can identify the most effective antigenic determinants (epitopes) on a pathogen, which are the parts of the pathogen that the immune system recognizes and targets for attack. This helps researcher’s focus on the most promising vaccine candidates. Immunogenic Design AI technology can optimize the need of design of vaccines to ensure they are safe and effective. This includes how the vaccine will interact with the immune system and the best way to deliver the vaccine to the body. Prediction of Immune Response AI can model the immune response to potential vaccines, allowing researchers to predict how well vaccine can work and what side effects, adverse effect can be occurred and how it can be overcome. Tailored Vaccine With the help of AI one can craft to fit the person needs accordingly. Researcher can continue discovery the vaccine as per the need of individual genetic information or immune response and possible sparse Auto encoders (SAEs). For example, COVID-19 pandemic confirmed how quickly mRNA vaccines can be designed and produced against a novel pathogen. It is also being used in the development of treatments for non-infectious diseases, such as cancer. Ai Plays Major Role for Improved Diagnosis And Treatment of Bacterial Infections In 2023, study showed that Artificial intelligence plays progressively vital role in the healthcare, providing intensified diagnostic accuracy, custom treatment strategies and improved patient compliance. The use of machine learning for cancer diagnosis and staging from molecular data has in fact been around since the early 2000’s, where machine learning approaches such as clustering, support vector machine and artificial neural networks were applied to microarray-based expression profiles for cancer classification and by analyzing the medical data, various information from the health sectors, patient medical history, genetic information all these help in better and improved diagnosis. For instance, AI has become a powerful tool in the tailored medication generally in cancer and infectious disease. AI helps in improving the accuracy and reliability in screening the cancer disease and detection method that is minimally invasive techniques such as liquid biopsies for circulating tumor DNA (ctDNA) or cfDNA, blood test allow for early detection of cancer, monitoring risk of relapse over time and guiding treatment options. As an example, MSI status can be predicted from ctDNA in endometrial cancer patients in order to inform immunotherapy- based treatment. Developed a machine learning based approach, Lung-CLiP (cancer likelihood in plasma), that predicts the likelihood of ctDNA in blood drawn from lung cancer patients. So, the death rate can be decreased by earlier detection of cancer with the AI models. Usually, at last stage of the cancer patient gets to know. AI Assisted Diagnosis of Bacterial Vaginosis (BV) and (Vulvovaginal candidiasis) VVC in Vagina VVC is the yeast infection that affects women worldwide. It is characterized by overgrowth of the yeast Candida albicans. Overgrowth often occurs when there is imbalance between the vaginal microbiome resulting in vaginal itching, burning sensation, unusual discharge and discomfort during intercourse time. Around the Pa ge 65 https://journals.e-palli.com/home/index.php/ajmsi Am. J. Med. Sci. Innov. 4(2) 53-72, 2025 world 75% of women suffered from bacterial vaginosis (BV). This study aims to develop a novel method for BV detection by integrating surface-enhanced Raman scattering (SERS) with machine learning (ML) algorithms. Figure 7: Microscopic image of overgrowth of Vagina cells Figure 8: represents microscopic images of normal vagina and vagina affected by bacterial infection In recent years, AI algorithms particularly, Convolutional Neural Network (CNN) models gained the importance in analyzing microscopic images to identify and classify the microorganisms, bacterial vaginosis (BV) and VVC (Vulvovaginal candidiasis) which help the doctors to treat the infection accurately and can even be used to predict the effectiveness of different treatments and potential complications. AI-assisted tool like CombiANT used to quantify the antimicrobial synergy and for the treatment of infection caused by BV. A cascaded deep neural network model is used to diagnosis VVC, demonstrating superior characteristics exactly as compared to experts. Therefore, this model holds potential for clinical application to aid in the diagnosis of VVC. The diagnosis of VVC requires identifying yeast pseudohyphae, budding yeast, and yeast from microscope images, necessitating the use of object detection CNN models. R-CNN series and YOLO series CNN models have achieved notable success in target detection tasks in recent years. Convolutional Neural Network (CNN) models have transcended human performance such as image’s visual elements and image of object detection. But CNN models diagnosis the medical images very smoothly, quickly in less time. Pa ge 66 https://journals.e-palli.com/home/index.php/ajmsi Am. J. Med. Sci. Innov. 4(2) 53-72, 2025 AI Helps in Microbial Diagnosis AI is being used in various ways to examine the growth of microbial infections as traditional microbial diagnosis faces challenges through detection process-culturing and isolating microorganisms consume time, false positives, cross contamination and difficult for data surveillance. AI tool deep learning, a subset of ML, relies on artificial neural networks (ANNs) which analyze complex datasets (shape and structure of microbial images or genetic information of pathogens) and all other relevant information to identify pathogens, predict antibiotic resistance. By convolutional neural networks (CNNs) in digital pathology, automated bacterial classification, and colony counting further underscores AI’s versatility. Moreover, AI improves antimicrobial susceptibility assessment and contributes to disease surveillance, outbreak forecasting, and real-time monitoring. Thus, AI tool show promising paradigm-shifting advancements in healthcare. Apart from this, by incorporating the data record into DL, it enhances the detection of cancer metastases in lymph nodes, prostate cancer and scoring ki67 in breast cancer. DL accelerates the process of analyzing data, resulting in fast mode result speed and precision. Recent progressions in AI, particularly ML methodologies, are explored to study SARS-CoV-2, malaria, and mycobacteria serve to demonstrate AI’s potential for quick and4 precise diagnosis. In the context of the SARS-CoV-2 pandemic, AI and CNNs has increasingly a spectrum of applications such as virus genome sequencing that helps in decision making algorithms, discovery of new molecule of drug and shot development. AI and CNNs integration into pathology laboratories can elevate the precision of identifying microorganisms present on cytological and histological slides that diagnosis the COVID-19 causative agent, severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) using the PCR testing (blood sample and serum of the patient can also be taken for testing) that identify the atypical profiles indicative of tainted, thus facilitating the rapid and accurate diagnosis while minimizing false evidence. AI in Assisting in Diagnosis of Infectious Skin Disease As we know, the largest organ of human body is the skin. It covers all the body surface area and composed of epidermis, dermis and hypodermis layers. Skin act as a protective barrier for external factor such as bacteria, chemicals and temperature changes. Various micro- organisms residence on the skin surface like bacteria (Staphylococcus, Corynebacterium) fungi (Malassezia) and viruses (Herpes simplex, shingles) that inhibit the colonization of pathogens. Therefore, the rapid diagnosis of skin lesions is utmost importance for treatment of infectious diseases. In dermatology, AI has shown great promise in diagnosing skin conditions by analyzing medical images. AI algorithms have been developed to evaluate images of the skin to detect and classify conditions such as melanoma, psoriasis and acne. These algorithms can enhance the diagnostic capabilities of dermatologists by providing a second opinion or flagging potential issues that may not be immediately apparent to the human eye. The integration of AI into dermatology not only improves diagnostic accuracy but also increases efficiency by reducing the time required to analyze images. With the growth of AI, it aid in the dermatology in predicting disease progression and developing new treatments. AI can help in the early detection of skin cancer and other infectious diseases which lead to timely treatment and better outcomes. AI tool deep learning and Convolutional neural networks (CNNs) gaining the importance in diagnosis of infection of skin. It provide medical image recognition, interpretation combining with histopathology to identify specific cells in images and further it combine with image to identify key features to diagnosis of various diseases such as cardiovascular diseases, endocrine diseases and tumors (Hutchinson et al., 2023; Giorgini et al., 2024; Makimoto & Kohro, 2024). CNNs can also assist individuals with the diagnosis of monkeypox skin lesions. Monkeypox caused by monkeypox virus (MPXV) it is zoonotic disease, characterized by skin lesions that present on macules and papules and later entered into vesicles, pustules. So, Figure 9: Artificial intelligence –assisted diagnostic model Pa ge 67 https://journals.e-palli.com/home/index.php/ajmsi Am. J. Med. Sci. Innov. 4(2) 53-72, 2025 CNNs helps to detect the MPXV lesions and find out the best treatment to be given to patient which must be patient compliance, personalized medication can also be planned by optimizing the patient data. Overall, AI holds promising revolution in dermatology and improving patient care. Challenges remain but AI increasing the valuable tool in the fight against skin disease. Ongoing research and development in future will minimize the obstacles thus, AI models will more likely to cover the datasets complex and convert to easy integration. AI Revolution In Diagnosis And Management of Fungal Nail Infection Nail infection is caused by fungal infection namely, onychomycosis. It is difficult to diagnosis onychomycosis fungal nail infection as it’s similar to other nail conditions. The current methods to examine fungal infection of nails include microscopic examination with potassium hydroxide, fungal cultures and periodic acid- Schiff biopsy staining. Culture is considered a gold standard for fungal identification that helps to determine the viability and pathogen species, but often requires 4–6 weeks for results due to the slow-growing nature of many fungi. Culture media may get contaminated by environmental factors but use of antimicrobial solutions inhibits bacterial growth in culture media. All these techniques are time consuming, variable sensitivity, costly and based upon human reliability and interpretation. Inspite of these, Molecular techniques, such as PCR (Polymerase Chain Reaction) and MALDI-TOF MS (Matrix- Assisted Laser Desorption–Ionisation–Time of Flight Mass Spectrometry) are significantly helpful in fungal diagnosis due to their ability to swiftly detect fungi with high sensitivity, often within a few hours. Moving on, undecylenic acid is a fatty acid that helps in the preventing the fungus nail growth. Dermoscopy is a technique used to examine the skin and its adnexa in detail, with magnification up to 10 times. This enhances the identification of features that are not visible to the naked eye, aiding in the identification of skin conditions. The procedure has emerged as a valuable tool in onychomycosis diagnosis, offering a non-invasive, rapid, and precise method for evaluating nail abnormalities. Onychoscopy reveals distinct characteristics that facilitate the pattern of fungal nail destruction and differentiation from other nail disorders. These features include a jagged proximal margin, longitudinal striae with multicolor vertical streaks, and spiked patterns indicative of fungal invasion. Artificial intelligence has made advancements in medicine, utilizing the machine learning, deep learning and other AI technologies to analyze complex medical datasets, enhance diagnostic accuracy, tailored treatment plans and improve patient compliance. Mostly the AI studies show accurate results. Deep learning model particularly, CNNs used to detect and classify fungal infections from images. Even machine learning algorithms helps in predicting treatment outcomes and personalized treatment based upon individual patient characteristics. One of the most significant challenges is obtaining a large number of robust data for the training dataset of high quality and standards. These data is essential to assure that AI is used its potential and improves patient outcomes. In addition, patient consent, data privacy, bias etc medico-legal issues. By studying these issues can be resolve and ensure that AI is ethically and safely for use in the clinical practice. Figure 10: List of Infectious Diseases Challenges of AI in the Medical Field While the application of artificial intelligence (AI) in treating bacterial infections shows great potential, realizing its full effectiveness necessitates overcoming considerable challenges. A primary barrier is the issue of data, which includes both its volume and integrity. Privacy concerns and regulatory constraints often hinder the collection, standardization, and sharing of data related to bacterial infections. These limitations make it difficult to access large, diverse datasets that are Pa ge 68 https://journals.e-palli.com/home/index.php/ajmsi Am. J. Med. Sci. Innov. 4(2) 53-72, 2025 essential for developing robust AI models. Consequently, AI applications in healthcare environments become less effective and applicable in other contexts (Cath, 2018; Baowaly et al., 2019; Hummel & Braun, 2020). The inherent complexity of bacterial diseases poses additional challenges. The swift mutation rates and diverse infection mechanisms of bacterial pathogens make it difficult to predict bacterial behavior and accurately assess antibiotic sensitivity. AI models in this domain must integrate knowledge from various disciplines, such as microbiology, genetics, biochemistry, and computer science. Developing comprehensive models requires significant resources and expertise, posing a considerable challenge for researchers working within constraints. The lack of a thorough legal framework and standardized norms for AI applications in the healthcare sector presents a considerable challenge. As AI technology progresses, it is essential to develop and regularly update laws to ensure its ethical, safe, and effective use in treating bacterial diseases. The establishment of clear guidelines and oversight will be vital in addressing issues related to accountability, bias, and the equitable implementation of AI systems in clinical settings (Rees & Müller, 2022). Tackling these challenges requires interdisciplinary cooperation, the creation of strict data sharing regulations, the adoption of transparent AI models, and the development of comprehensive regulatory frameworks. By overcoming these obstacles, AI has the potential to significantly enhance the detection and treatment of bacterial infections, paving the way for innovative and personalized healthcare solutions. RESULTS AND DISCUSSIONS Artificial Intelligence is transforming the diagnosis, treatment, and prevention of bacterial infections by facilitating quicker and more precise identification of pathogens, enhancing antimicrobial susceptibility testing, and advancing genomic analysis. AI-driven tools are also contributing to the early detection of outbreaks, the formulation of personalized treatment strategies, and the creation of novel drugs and vaccines. Nevertheless, challenges persist regarding data quality, model interpretability, and ethical issues, including data privacy Enhanced Diagnosis and Identification Quicker and More Precise Identification AI algorithms, especially those employing machine learning and deep learning techniques, are capable of examining intricate datasets from diverse sources (such as MALDI-TOF MS and genome sequencing) to swiftly and accurately identify pathogens. Illustration A research study integrated MALDI-TOF MS with ClinProTools software for the prompt identification of Staphylococcus aureus subspecies, achieving a remarkable 100% accuracy through genetic analysis and an efficient classifier model. AI-Driven Image Analysis AI technology can scrutinize medical images (including X-rays and CT scans) to identify indications of infection, facilitating early diagnosis and the isolation of infected individuals, which is particularly crucial during pandemic scenarios. Transfer learning and convolutional neural networks (CNNs) utilized for CX-R and CT imaging have demonstrated significant accuracy in identifying COVID-19. Tackling Issues In Low-Resource Environments Artificial Intelligence (AI) can facilitate affordable, smartphone-based image analysis and cloud-based diagnostic solutions for bacterial identification in areas with limited resources. Improved Antimicrobial Susceptibility Testing (AST) Enhancing Treatment AI has the capability to evaluate bacterial genomes and susceptibility information to forecast antibiotic resistance and assist in choosing the most effective treatment options. Illustration AI-driven decision support systems can suggest the best antibiotic therapies based on patient information and local resistance trends. Accelerating Drug Discovery AI has the capability to forecast the effectiveness of novel drug compounds and pinpoint potential antibacterial agents, thereby expediting the creation of new treatments. Prevention and Control Early outbreak detection: AI is able to scrutinize extensive datasets to detect early signs of bacterial infection epidemics, facilitating prompt preventative measures. Example: Machine learning algorithms can assess the likelihood of severe sepsis in ICU patients, notifying healthcare professionals and allowing for proactive treatment. Infection Control in Healthcare Facilities AI can evaluate data regarding patient and staff interactions to comprehend the transmission of infections, supporting the formulation of targeted infection control strategies Challenges and Ethical Considerations Data quality and quantity: For AI models to be effective, they necessitate extensive and high-quality datasets. Model Interpretability It is essential to comprehend how AI algorithms arrive at decisions in order to foster trust and guarantee responsible usage. Ethical Concerns Issues such as patient privacy, algorithmic bias, and data Pa ge 69 https://journals.e-palli.com/home/index.php/ajmsi Am. J. Med. Sci. Innov. 4(2) 53-72, 2025 security must be tackled to ensure the equitable and ethical implementation of AI. Future Directions Interdisciplinary Collaboration Integrating AI with additional technologies such as synthetic biology and nanomedicine has the potential to yield more effective strategies for addressing antibiotic resistance and various infectious diseases. Continued Innovation Persistent research and advancement in AI algorithms, data analysis methods, and hardware will be essential for unlocking the complete capabilities of AI in the fight against bacterial infections. Discussions The predominant AI applications utilized in clinical environments were largely characterized by Machine Learning algorithms (ML), including Logistic Regression (LR), Random Forest (RF), Support Vector Machines (SVMs), and Decision Trees (DTs). These models were mainly employed for pathogen identification, early detection of infections, and risk evaluation of healthcare- associated infections (HAIs). This model demonstrated the high diagnostic precision of ML algorithms in identifying antibiotic-resistant pathogens, underscoring AI’s vital contribution to infection control in healthcare environments. The significance of various AI-enabled applications in infection control, with the potential to improve diagnostic accuracy, optimizes workflows, and mitigates the transmission of infectious diseases. Several research efforts have employed advanced AI tools, including L2-regularized Logistic Regression models, to enhance clinical decision-making in the realm of infection control. Within clinical environments, AI aids in alleviating the impact of HAIs by delivering precise, real-time predictions and diagnostics, while also propelling research into innovative infection control techniques and therapeutic approaches. These consistent results emphasize the transformative capabilities of AI across different areas of infection control, in line with the goals and expected results of the scoping review. The incorporation of sophisticated AI systems, whether through Machine Learning, Deep Learning, or hybrid methodologies, is essential in improving the efficacy of infection prevention and control initiatives, ultimately leading to enhanced public health outcomes on a global scale. Summary With the AI tools we can get multiply of benefits as a result Properly Identification of Pathogen: AI algorithms can accurately identify bacterial pathogens therefore, reducing diagnostic time and improving treatment accuracy. Early Detection of Antimicrobial Resistance: AI can analyze genomic data to identify resistance early thus, enabling timely and targeted interventions. Tailored Treatment: AI-powered tools help to select the antibiotics for individual patients, optimizing treatment outcomes and minimizing the risk of resistance development. Monitoring the response: AI can be used for surveillance and monitoring of infectious diseases, facilitating early outbreak detection and rapid response. AI-Assisted Imaging: AI algorithms can analyze medical images (like X-rays and CT scans) to aid in diagnosis, particularly in cases like COVID-19, where early identification and isolation are crucial. Improved Diagnostic Precision: AI models have shown high accuracy in diagnosing various, enhancing clinical decision-making. CONCLUSION AI have a significant promise for revolutionizing bacterial infection diagnosis and treatment by improving efficiency, accuracy, and personalized medicine approaches. However, addressing ethical concerns related to data privacy, algorithmic biases and healthcare outcomes. With the aid of AI imaging identification and diagnosis of bacteria can easily notify, help in choosing the appropriate antibiotics in the bacterial infection. Utilizing advanced technologies like machine learning and deep learning, AI has been implemented in several critical domains, ranging from swift pathogen detection and antimicrobial susceptibility assessment to the analysis of intricate genomic data and the creation of tailored treatment strategies. Through highly refined algorithms, AI technology not only significantly enhances the speed and precision of pathogen identification but also accurately forecasts the susceptibility of pathogens to particular antibiotics based on historical data, thereby offering robust scientific decision support for healthcare professionals. Likewise, in the realm of epidemiological surveillance, AI bolstered the capacity for real-time monitoring and early warning regarding the spread of bacterial infectious diseases by analyzing and processing vast amounts of epidemiological data, thus providing a powerful analytical tool and foundation for public health decision-making. With the assistance of AI, healthcare professionals will be more adept at tackling the challenges presented by bacterial infections, further propelling medical practice towards enhanced precision, efficiency, and personalization, ultimately striving to provide the highest quality of care and treatment for patients. REFERENCES Abbasi, B. A., Saraf, D., Sharma, T., Sinha, R., Singh, S., Sood, S., et al. (2022). Identification of vaccine targets & design of vaccine against SARS-CoV-2 coronavirus using computational and deep learning- based approaches. PeerJ, 10, e13380. https://doi. org/10.7717/peerj.13380 Abu-Aqil, G., Lapidot, I., Salman, A., & Huleihel, M. (2023). Quick detection of Proteus and Pseudomonas in patients’ urine and assessing their antibiotic Pa ge 70 https://journals.e-palli.com/home/index.php/ajmsi Am. J. Med. Sci. Innov. 4(2) 53-72, 2025 susceptibility using infrared spectroscopy and machine learning. Sensors, 23(8132). https://doi. org/10.3390/s23198132 Adams, C., Beller, E., Clark, J., & Tsafnat, G. (n.d.). Making progress with the automation of systematic reviews: Principles of the International Collaboration for the Automation of Systematic Reviews (ICASR). Aggarwal, S., Dhall, A., Patiyal, S., Choudhury, S., Arora, A., & Raghava, G. P. S. (2023). An ensemble method for prediction of phage-based therapy against bacterial infections. Frontiers in Microbiology, 14, 1148579. https://doi.org/10.3389/fmicb.2023.1148579 Alami, H., Lehoux, P., Denis, J.-L., Motulsky, A., Petitgand, C., & Savoldelli, M. (2020). Organizational readiness for artificial intelligence in health care: Insights for decision-making and practice. Journal of Health Organization and Management, 35, 106–114. https://doi.org/10.1108/JHOM-03-2020-0074 Aljaaf, A. J., Al-Jumeily, D., Hussain, A. J., Fergus, P., Al- Jumaily, M., & Abdel-Aziz, K. (n.d.). Toward an optimal use of artificial intelligence techniques within a clinical decision support system. American Society for Microbiology. (2016). Biochemical tests for the identification of aerobic bacteria. In Clinical Microbiology Procedures Handbook (Vol. 3.17.1.1–3.17.48.3). https://doi.org/10.1128/9781555818814.ch3.17.1 Andrews, D., Chetty, Y., Cooper, B. S., Virk, M., Glass, S. K., Letters, A., Kelly, P. A., Sudhanva, M., & Jeyaratnam, D. (2017). Multiplex PCR point of care testing versus routine, laboratory-based testing in the treatment of adults with respiratory tract infections: A quasi-randomised study assessing impact on length of stay and antimicrobial use. BMC Infectious Diseases, 17, 671. https://doi.org/10.1186/s12879-017-2784-z Avni, T., Bieber, A., Green, H., Steinmetz, T., Leibovici, L., & Paul, M. (2016). Diagnostic accuracy of PCR alone and compared to urinary antigen testing for detection of Legionella spp.: A systematic review. Journal of Clinical Microbiology, 54(2), 401–411. https:// doi.org/10.1128/JCM.02675-15 Baggett, H. C., Rhodes, J., Dejsirilert, S., Salika, P., Wansom, T., Jorakate, P., Kaewpan, A., Olsen, S. J., Maloney, S. A., & Peruski, L. F. (2012). Pneumococcal antigen testing of blood culture broth to enhance the detection of Streptococcus pneumoniae bacteremia. European Journal of Clinical Microbiology & Infectious Diseases, 31(5), 753–756. https://doi.org/10.1007/ s10096-011-1370-3 Baker, J., Timm, K., Faron, M., Ledeboer, N., & Culbreath, K. (2020). Digital image analysis for the detection of group B Streptococcus from ChromID Strepto B medium using PhenoMatrix algorithms. Journal of Clinical Microbiology, 59, e01902-19. https:// doi.org/10.1128/JCM.01902-19 Bean, H. D. (2012). Bacterial volatile discovery using solid-phase microextraction and comprehensive two- dimensional gas chromatography–time-of-flight mass spectrometry. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. https:// doi.org/10.1016/j.jchromb.2012.03.021 Berke, A., & Tilton, R. C. (1986). Evaluation of rapid coagulase methods for the identification of Staphylococcus aureus. Journal of Clinical Microbiology, 23, 916–919. Bilgin, G. B., Bilgin, C., Burkett, B. J., Orme, J. J., Childs, D. S., & Thorpe, M. P. (2024). Theranostics and artificial intelligence: New frontiers in personalized medicine. Theranostics, 14, 2367–2378. https://doi.org/10.7150/ thno.94788 Burkovski, A. (2022). Host–pathogen interaction 3.0. International Journal of Molecular Sciences, 23, 12811. https://doi.org/10.3390/ijms232112811 Cath, C. (2018). Governing artificial intelligence: Ethical, legal and technical opportunities and challenges. Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences, 376(2133), 20180080. https://doi.org/10.1098/rsta.2018.0080 Centers for Disease Control and Prevention. (2022). COVID-19: U.S. Impact on antimicrobial resistance, special report 2022. https://doi.org/10.15620/cdc:117915 Cheng, J., & Druzdzel, M. J. (2000). AIS-BN: An adaptive importance sampling algorithm for evidential reasoning in large Bayesian networks. Journal of Artificial Intelligence Research, 13, 155–188. https://doi. org/10.1613/jair.650 Cherkaoui, A., Renzi, G., Charretier, Y., Blanc, D. S., Vuilleumier, N., & Schrenzel, J. (2019). Automated incubation and digital image analysis of chromogenic media using Copan WASPLab enables rapid detection of vancomycin-resistant Enterococcus. Frontiers in Cellular and Infection Microbiology, 9, 379. https://doi. org/10.3389/fcimb.2019.00379 Cisek, A. A., Dąbrowska, I., Gregorczyk, K. P., & Wyżewski, Z. (2017). Phage therapy in bacterial infections treatment: One hundred years after the discovery of bacteriophages. Current Microbiology, 74(3), 277–283. https://doi.org/10.1007/s00284-016-1166-x Couturier, M. R., Graf, E. H., & Griffin, A. T. (2014). Urine antigen tests for the diagnosis of respiratory infections: Legionellosis, histoplasmosis, pneumococcal pneumonia. Clinical Laboratory Medicine, 34(2), 219–236. https://doi.org/10.1016/j. cll.2014.02.002 D’Haen, J. (n.d.). Integrating expert knowledge and multilingual web crawling data in a lead qualification system. Deelder, W., Napier, G., Campino, S., Palla, L., Phelan, J., & Clark, T. G. (2022). A modified decision tree approach to improve the prediction and mutation discovery for drug resistance in Mycobacterium tuberculosis. BMC Genomics, 23, 46. https://doi. org/10.1186/s12864-022-08291-4 Deusenbery, C., Wang, Y., & Shukla, A. (2021). Recent innovations in bacterial infection detection and treatment. ACS Infectious Diseases, 7(3), 695–720. https://doi.org/10.1021/acsinfecdis.0c00890 Dou, X., Yang, F., Wang, N., Xue, Y., Hu, H., & Li, B. Pa ge 71 https://journals.e-palli.com/home/index.php/ajmsi Am. J. Med. Sci. Innov. 4(2) 53-72, 2025 (2023). Rapid detection and analysis of Raman spectra of bacteria in multiple fields of view based on image stitching technique. Frontiers in Bioscience-Landmark, 28, 249. https://doi.org/10.31083/j.fbl2810249 Dwivedi, Y. K., Hughes, D. L., Coombs, C., Constantiou, I., Duan, Y., Edwards, J. S., Gupta, B., Lal, B., Misra, S., Prashant, P., & Raman, R. (2020). Impact of COVID-19 pandemic on information management research and practice: Transforming education, work and life. International Journal of Information Management, 55, 102211. https://doi.org/10.1016/j. ijinfomgt.2020.102211 Ekins, S., Godbole, A. A., Kéri, G., Orfi, L., Pato, J., & Bhat, R. S. (2017). Machine learning and docking models for Mycobacterium tuberculosis topoisomerase I. Tuberculosis (Edinburgh), 103, 52–60. https://doi.org/10.1016/j.tube.2017.01.005 Ernst, D., Bolton, G., Recktenwald, D., Cameron, M. J., Danesh, A., & Persad, D. (2006). Bead-based flow cytometric assays: A multiplex assay platform with applications in diagnostic microbiology. In Advanced Techniques in Diagnostic Microbiology (pp. 427–443). Springer US. https://doi.org/10.1007/978-0-387-32892-4_23 Gilbert, G. L., & Kerridge, I. (2020). Hospital infection prevention and control (IPC) and antimicrobial stewardship (AMS): Dual strategies to reduce antibiotic resistance (ABR) in hospitals. In Ethics and drug resistance: Collective responsibility for global public health (pp. 89–108). Springer. https://doi.org/10.1007/978- 3-030-27874-8_6 Goodswen, S. J., Barratt, J. L. N., Kennedy, P. J., Kaufer, A., Calarco, L., & Ellis, J. T. (2021). Machine learning and applications in microbiology. FEMS Microbiology Reviews, 45(3), fuab015. https://doi.org/10.1093/ femsre/fuab015 Ho, C.-S., Jean, N., Hogan, C. A., Blackmon, L., Jeffrey, S. S., & Holodniy, M. (2019). Rapid identification of pathogenic bacteria using Raman spectroscopy and deep learning. Nature Communications, 10, 4927. https://doi.org/10.1038/s41467-019-12898-9 Howard, A., Aston, S., Gerada, A., Reza, N., Bincalar, J., & Mwandumba, H. (2024). Antimicrobial learning systems: An implementation blueprint for artificial intelligence to tackle antimicrobial resistance. The Lancet Digital Health, 6(2), e79–e86. https://doi. org/10.1016/S2589-7500(23)00221-2 Hummel, P., & Braun, M. (2020). Just data? Solidarity and justice in data-driven medicine. Life Sciences, Society and Policy, 16, 8. https://doi.org/10.1186/s40504-020- 00101-7 Hutchinson, D., Kunasekaran, M., Quigley, A., Moa, A., & MacIntyre, C. R. (2023). Could it be Monkeypox? Use of an AI-based epidemic early warning system to monitor rash and fever illness. Public Health, 220, 142– 147. https://doi.org/10.1016/j.puhe.2023.05.010 Kassis, C., Zaidi, S., Kuberski, T., Moran, A., Gonzalez, O., & Hussain, S. (2015). Role of Coccidioides antigen testing in the cerebrospinal fluid for the diagnosis of coccidioidal meningitis. Clinical Infectious Diseases, 61(10), 1521–1526. https://doi.org/10.1093/cid/civ585 Kaufmann, E., Chacon, A., Kausel, E. E., Herrera, N., & Reyes, T. (2023). Task-specific algorithm advice acceptance: A review and directions for future research. Data and Information Management, 7(1), 100040. https://doi.org/10.1016/j.dim.2023.100040 Khaledi, A., Schniederjans, M., Pohl, S., Rainer, R., Bodenhofer, U., & Xia, B. Y. (n.d.). Transcriptome profiling of antimicrobial resistance in Pseudomonas aeruginosa. King, K. P. (2009). The handbook of the evolving research of transformative learning: Based on the Learning Activities Survey. Information Age Publishing. Kotsiantis, S. B. (2007). Supervised machine learning: A review of classification techniques. Informatica, 31, 249–268. Ledro, C., Nosella, A., & Vinelli, A. (2022). Artificial intelligence in customer relationship management: Literature review and future research directions. Journal of Business & Industrial Marketing, 37(13), 48– 63. https://doi.org/10.1108/JBIM-02-2021-0092 Liu, G. (2023). Deep learning-guided discovery of an antibiotic targeting Acinetobacter baumannii. Nature Chemical Biology, 19, 1342–1350. https://doi. org/10.1038/s41589-023-01349-8 Miner, A. S. (2020). Chatbots in the fight against the COVID-19 pandemic. NPJ Digital Medicine, 3, 65. https://doi.org/10.1038/s41746-020-0280-0 Mintz, Y., & Brodie, R. (2019). Introduction to artificial intelligence in medicine. Minimally Invasive Therapy & Allied Technologies, 28(2), 73–81. https://doi.org/10.10 80/13645706.2019.1575864 Mizuno, S., Iwami, M., Kunisawa, S., Naylor, N., Yamashita, K., Kyratsis, Y., et al. (2018). Comparison of national strategies to reduce meticillin-resistant Staphylococcus aureus infections in Japan and England. Journal of Hospital Infection, 100(3), 280–298. https://doi.org/10.1016/j.jhin.2018.06.026 Oh, J. (2018); Tilton, S. C., & Johnson, M. (2019). Assessing susceptibility for polycyclic aromatic hydrocarbon toxicity in an in vitro 3D respiratory model for asthma. Oh, J., Makar, M., Fusco, C., McCaffrey, R., Rao, K., & Ryan, E. E. (2018). A generalizable, data-driven approach to predict daily risk of Clostridium difficile infection at two large academic health centers. Infection Control & Hospital Epidemiology, 39(4), 425–433. https://doi.org/10.1017/ice.2018.16 Østerlund, C., Jarrahi, M. H., Willis, M., Boyd, K., & Wolf, C. T. (2021). Artificial intelligence and the world of work: A co-constitutive relationship. Journal of the Association for Information Science and Technology, 72(1), 128–135. https://doi.org/10.1002/asi.24420 Paquin, P., Durmort, C., Paulus, C., Vernet, T., Marcoux, P. R., & Morales, S. (2022). Spatio-temporal based deep learning for rapid detection and identification of bacterial colonies through lens-free microscopy time- lapses. PLOS Digital Health, 1(1), e0000122. https:// Pa ge 72 https://journals.e-palli.com/home/index.php/ajmsi Am. J. Med. Sci. Innov. 4(2) 53-72, 2025 doi.org/10.1371/journal.pdig.0000122 Pentina, I., Xie, T., Hancock, A., & Bailey, A. (2023). Consumer–machine relationships in the age of artificial intelligence: Systematic literature review and research directions. Psychology & Marketing. https:// doi.org/10.1002/mar.22042 Perkins, M. D., Mirrett, S., & Reller, L. B. (1995). Rapid bacterial antigen detection is not clinically useful. Journal of Clinical Microbiology, 33(6), 1486–1491. https://doi.org/10.1128/jcm.33.6.1486-1491.1995 Porcel, J. M. (2018). Biomarkers in the diagnosis of pleural diseases: A 2018 update. Therapeutic Advances in Respiratory Disease, 12, 1753466618808660. https:// doi.org/10.1177/1753466618808660 Rahman, T., Khandakar, A., Rahman, A., Zughaier, S. M., Al Maslamani, M., Chowdhury, M. H., Tahir, A. M., Hossain, M. S. A., & Chowdhury, M. E. H. (2024). TB-CXRNet: Tuberculosis and drug-resistant tuberculosis detection technique using chest X-ray images. Cognitive Computation, 16, 1393–1412. https:// doi.org/10.1007/s12559-023-10267-7 Rees, C., & Müller, B. (2022). All that glitters is not gold: Trustworthy and ethical AI principles. AI and Ethics, 3(3), 1241–1254. https://doi.org/10.1007/s43681- 022-00232-x Srivastava, B., & Rossi, F. (2019). Rating AI systems for bias to promote trustable applications. Talaei-Khoei, A., Yang, A. T., & Masialeti, M. (2024). How does incorporating ChatGPT within a firm reinforce agility-mediated performance? The moderating role of innovation infusion and firms’ ethical identity. Technovation, 132, 102975. https://doi.org/10.1016/j. technovation.2023.102975 Venkatachalam, S., & Ray, A. (2022). How do context- aware artificial intelligence algorithms used in fitness recommender systems? A literature review and research agenda. Journal of Innovation & Knowledge in Emerging Markets. https://doi.org/10.1016/j. jjimei.2022.100139 Viasus, D., Calatayud, L., McBrown, M. V., Ardanuy, C., & Carratalà, J. (2019). Urinary antigen testing in community-acquired pneumonia in adults: An update. Expert Review of Anti-Infective Therapy, 17(2), 107–115. https://doi.org/10.1080/14787210.2019.1565994 Walker, D. H. (2014). Principles of diagnosis of infectious diseases. In Pathobiology of human disease (pp. 222–225). Amsterdam, The Netherlands: Elsevier. Wan, F. (2024). Deep-learning-enabled antibiotic discovery through molecular de-extinction. Nature Biomedical Engineering. https://doi.org/10.1038/s41551-024-01201-x Wong, F. (2023). Leveraging artificial intelligence in the fight against infectious diseases. Science, 381(6653), 164–170. https://doi.org/10.1126/science.abq4000 Zulderwijk, A. (2021). Implications of the use of artificial intelligence in public governance: A systematic literature review and a research agenda. Government Information Quarterly, 38(3), 101577. https://doi. org/10.1016/j.giq.2021.101577